Beijing suspends PwC's China unit for six months in record penalty over Evergrande audit

Business News

Beijing suspends PwC's China unit for six months in record penalty over Evergrande audit
China Evergrande GroupTencent Holdings LtdAlibaba Group Holding Ltd
  • 📰 CNBC
  • ⏱ Reading Time:
  • 47 sec. here
  • 6 min. at publisher
  • 📊 Quality Score:
  • News: 36%
  • Publisher: 72%

Regulators hit PwC's auditing unit in China with a six-month business suspension and a 441 million yuan fine over the firm's audit of China Evergrande Group.

Investor confidence in China's real estate market appear to be boosted by the government's promise to support the sector and some loosening of policies. But analysts say China's high-growth property market may be a thing of the past.

Chinese authorities have been examining PwC's role in Evergrande's accounting practices since the CSRC accused the developer in March of aThe business suspension and fines are the toughest ever penalty received by a Big Four accounting firm in China, and come against the backdrop of an As part of the penalties, PwC Zhong Tian will be barred from signing off on certain key documents for clients in mainland China such as results and IPO applications in the next six months.

"We are disappointed by PwC Zhong Tian's audit work of Hengda, which fell unacceptably below the standards we expect of member firms of the PwC network," PwC network, the alliance of PwC's global member units, said in a statement. The CSRC said in its statement it had fined PwC Zhong Tian 325 million yuan, close to the total amount of penalties imposed by the regulator on over 50 auditors in the past three years.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNBC /  🏆 12. in US

China Evergrande Group Tencent Holdings Ltd Alibaba Group Holding Ltd Business News

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

China hands PwC a 6-month ban and fine over audit of the collapsed developer EvergrandeChina hands PwC a 6-month ban and fine over audit of the collapsed developer EvergrandeChinese authorities have banned the accounting firm PwC for six months and fined it over $56 million for its involvement in the audit of collapsed local property developer Evergrande.
Read more »

PwC China faces six-month business ban, large fine over Evergrande audit, sources sayPwC China faces six-month business ban, large fine over Evergrande audit, sources sayRegulators will likely order business suspension for a big part of PricewaterhouseCoopers' auditing unit in mainland China for six months, five sources said.
Read more »

PwC Banned for Six Months, Fined Over $56 Million in China Over Evergrande AuditPwC Banned for Six Months, Fined Over $56 Million in China Over Evergrande AuditChinese authorities have imposed the heaviest penalty yet on an international accounting firm operating in China. PwC has been banned from signing off on financial results for six months and fined over $56 million for its involvement in the audit of collapsed property developer Evergrande.
Read more »

China fines PwC $62 million for its role in the Evergrande collapseChina fines PwC $62 million for its role in the Evergrande collapseChinese regulators have hit PwC’s auditing unit in mainland China with a six-month business suspension and a record fine of 441 million yuan ($62 million) over the firm’s audit of troubled property developer China Evergrande Group.
Read more »

Analysis-China Evergrande subsidiary dealings raises prospects for offshore creditorsAnalysis-China Evergrande subsidiary dealings raises prospects for offshore creditorsAnalysis-China Evergrande subsidiary dealings raises prospects for offshore creditors
Read more »

Principal Investigator Positions at the Institute for Molecular and Cellular Therapy, CIMR, Beijing - Beijing, China job with The Chinese Institutes for Medical Research (CIMR), BeijingPrincipal Investigator Positions at the Institute for Molecular and Cellular Therapy, CIMR, Beijing - Beijing, China job with The Chinese Institutes for Medical Research (CIMR), BeijingThe Chinese Institutes for Medical Research, Beijing (CIMR, Beijing) is a brand-new research institution in Beijing, China. Its goal is to make ground-breaking discoveries in medical sciences and facilitate the translation of these discoveries into innovative products for patient care.
Read more »



Render Time: 2025-04-16 22:00:18